But these benefits are mostly from animal studies, and no major regulator has approved BPC157 for routine human therapy
[DOI] [PubMed] [Google Scholar] 71.Gojkovic S., Krezic I., Vrdoljak B., Malekinusic D., Barisic I., Petrovic A., Horvat Pavlov K., Kolovrat M., Duzel A., Knezevic M., et al
However, medical supervision helps ensure optimal dosing, appropriate monitoring, and safety when using multiple compounds simultaneously
We are talking about laboratory environments utilizing liquid chromatography-mass spectrometry, commonly deployed by anti-doping agencies like WADA (World Anti-Doping Agency) or USADA
See GLP-1 Peptides Explained for broader context on GLP-1 therapy